InvestorsHub Logo
Followers 11
Posts 1565
Boards Moderated 0
Alias Born 09/19/2006

Re: None

Thursday, 01/15/2015 12:43:06 PM

Thursday, January 15, 2015 12:43:06 PM

Post# of 6390
From listening to the CEO I got the impression the initial testing would start soon after the FDA approval. I agree BPTH in the past has not been timely. Perhaps by the second quarter we move into phase II?

The CEO claims they now have the personnel in place to run a successful phase II,move the other Grb-2 uses forward and develop the new drug Bcl-2. The have also improved the supply chain and are using a top of the line supplier with a back up.

Based on what the CEO said I suspect one of the problems with the first phase was that it was difficult to get participants as they had to be off all other treatment. That issue should be solved if a first line treatment can be used with Grb-2.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BPTH News